Published in Gene Therapy Weekly, April 19th, 2001
Sunil Chada, PhD, Introgen, presented the results of a preclinical study in a poster session at the 92nd Annual Meeting of the American Association for Cancer Research.
Earlier this year, Introgen announced that it was awarded a Small Business Innovation Research grant from the U.S. National Cancer Institute, which is funding this collaborative lung cancer research between Introgen and The University of Texas M.D. Anderson Cancer Center.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.